Semax BDNF Upregulation describes the documented effect where administration of the synthetic nootropic peptide Semax leads to an increase in the expression of Brain-Derived Neurotrophic Factor (BDNF) within neural tissues. This elevation in a key trophic factor is associated with enhanced synaptic plasticity and neuroprotection. It is a specific molecular outcome used to gauge Semax efficacy.
Origin
Semax is a synthetic analogue of the endogenous neuropeptide tuftsin, originating from Russian pharmacological research aimed at cognitive enhancement. BDNF upregulation refers to the increase in the gene expression of this vital neurotrophin.
Mechanism
Semax is hypothesized to interact with receptors that subsequently activate intracellular signaling pathways, such as the MAPK/ERK cascade, which directly promote the transcription of the BDNF gene. Increased BDNF then acts in an autocrine or paracrine fashion to strengthen existing synapses and support the survival of vulnerable neurons. This molecular mechanism underpins its utility in supporting cognitive resilience.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.